EI
CHRS icon

EFG International’s Coherus Oncology CHRS Stock Holding History

EFG International’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.1K Hold
11,500
– – ﹤0.01% 925
2026
Q1 		$19.4K Hold
11,500
– – ﹤0.01% 840
2025
Q4 		$16.3K Buy
+11,500
New +$16.8K ﹤0.01% 786

Other funds holding CHRS

TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $530M AUM 95.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

EFG International's CHRS Position: Q2 2026 in Review

EFG International held its Coherus Oncology (CHRS) position steady in Q2 2026 at 11,500 shares worth $16.1K. The position accounts for ﹤0.01% of the portfolio, ranked #925.

EFG International first reported a position in CHRS in Q4 2025 and has held it in 3 quarters since. The position peaked at $19.4K in Q1 2026. 146 funds tracked by Wall St. Rank hold CHRS as of Q2 2026.

  • EFG International held 11,500 shares of Coherus Oncology worth $16.1K as of Q2 2026.
  • EFG International left its Coherus Oncology share count unchanged in Q2 2026.
  • Coherus Oncology made up ﹤0.01% of EFG International's portfolio in Q2 2026, its #925 holding.
  • EFG International first reported a position in Coherus Oncology in Q4 2025 and has held it in 3 quarters since.
  • EFG International's Coherus Oncology position peaked at $19.4K in Q1 2026.
  • 146 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2026.

Based on EFG International's 13F filing for Q2 2026, filed 14 Aug 2026.